HighLife
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
€80MFinancing round
ParticipantEI
European Investment Bank
Activity from announced rounds
Activity in this selectionFrance
The European Investment Bank, abbreviated EIB, is the bank named in Reactive Technologies and Tensive financing announcements.
Recorded funding activity
Reactive measures electricity-grid inertia and stability in real time. Other recorded activity includes Morphotonics’ optical-component manufacturing equipment and HighLife’s transcatheter heart-valve technology. The bank remains distinct from the European Investment Fund and other institutions.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $91.7M 1 disclosed · full round size, not this investor’s share